Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, in some formulations, obesity
Of twelve patients receiving BPC-157 alone as an intra-articular injection, eleven reported meaningful pain improvement a 92% response rate
The known radioprotectant, WR-1065 (50 mg/kg, saline) was used as a control for radioprotection
252,253,254 SIRT3 can act as a tumor suppressor by inactivating HIF1 and decreasing oxidative stress
It is secreted following nutrient ingestion, resulting in enhanced glucose-stimulated insulin secretion (GSIS) from the pancreatic -cells as well as delayed gastric emptying and enhanced satiety, making it an attractive target for the treatment of T2D and obesity 3
At Aion Aesthetics, our GLP-1 medical weight loss program is designed for patients who want thoughtful medical oversight, ongoing support, and a clear treatment plan